Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Progressive Multifocal Leukoencephalopathy
Show Display Options
RSS Create an RSS feed from your search for:
Progressive Multifocal Leukoencephalopathy
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
2 Recruiting Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
3 Terminated
Has Results
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention: Drug: mefloquine
4 Completed Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)
Conditions: Leukoencephalopathy, Progressive Multifocal;   HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Tenofovir-Emtricitabine
5 Completed A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Interferon alfa-2b;   Drug: Zidovudine
6 Completed Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Filgrastim;   Drug: Cytarabine;   Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
7 Completed Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
8 Enrolling by invitation Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
9 Completed Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Intervention: Drug: Topotecan
10 Recruiting Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells
Condition: Leukoencephalopathy
Interventions: Biological: PyVST;   Other: No Intervention
11 Completed A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Cidofovir;   Drug: Probenecid
12 Terminated
Has Results
Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
Conditions: Immune Reconstitution Inflammatory Syndrome;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Methylprednisolone;   Drug: Prednisolone
13 Completed Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome
Conditions: PML;   AIDS
Intervention:
14 Completed JC Virus Reactivation in Multiple Sclerosis
Conditions: Progressive Multifocal Leukoencephalopathy;   Multiple Sclerosis
Intervention:
15 Active, not recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
16 Completed A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Intervention: Drug: Didanosine
17 Recruiting Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Condition: Kidney Transplantation
Intervention: Drug: No Intervention
18 Terminated Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Intervention: Drug: Interferon beta-1b
19 Recruiting Methylprednisolone During the Switch Between Natalizumab and Fingolimod
Condition: Multiple Sclerosis
Interventions: Drug: Methylprednisolone;   Drug: Placebo;   Drug: natalizumab (NTZ);   Drug: fingolimob (FTY)
20 Completed JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab
Condition: Relapsing Multiple Sclerosis
Intervention: Drug: natalizumab

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.